|
KIF13A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.3635537971245E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.72606373638473E-12 |
| Normal-vs-Stage2 |
7.96430000000736E-05 |
| Normal-vs-Stage3 |
2.683900E-03 |
| Normal-vs-Stage4 |
2.112500E-02 |
| Stage1-vs-Stage2 |
6.756200E-01 |
| Stage1-vs-Stage3 |
1.756170E-01 |
| Stage1-vs-Stage4 |
7.808400E-01 |
| Stage2-vs-Stage3 |
5.211400E-01 |
| Stage2-vs-Stage4 |
9.812800E-01 |
| Stage3-vs-Stage4 |
6.253000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.59234864077962E-12 |
| Normal-vs-AfricanAmerican |
2.25960028465977E-10 |
| Normal-vs-Asian |
1.359690E-03 |
| Caucasian-vs-AfricanAmerican |
6.034000E-01 |
| Caucasian-vs-Asian |
8.538200E-01 |
| AfricanAmerican-vs-Asian |
6.758400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99840144432528E-15 |
| Normal-vs-Female |
4.116600E-03 |
| Male-vs-Female |
1.428890E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.18519999989542E-07 |
| Normal-vs-Extreme_Weight |
1.87605486701159E-12 |
| Normal-vs-Obese |
1.82119999969643E-07 |
| Normal-vs-Extreme_Obese |
3.9471000023994E-08 |
| Normal_Weight-vs-Extreme_Weight |
3.671400E-01 |
| Normal_Weight-vs-Obese |
4.044000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.499800E-01 |
| Extreme_Weight-vs-Obese |
4.257500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.294800E-01 |
| Obese-vs-Extreme_Obese |
1.192390E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.263900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.991400377932E-10 |
| Normal-vs-Age(61-80Yrs) |
4.33098001906274E-13 |
| Normal-vs-Age(81-100Yrs) |
3.010000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.422000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.493400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.474440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.065800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.319000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.225400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.6858736628933E-12 |
| Normal-VS-Type2 PRCC |
1.57670000389132E-08 |
| Normal-VS-KIRP CIMP |
4.909400E-01 |
| Normal-VS-Unclassified PRCC |
1.971630E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.844000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.449880E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
2.626800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.366400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.265000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.513400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.64435132177232E-12 |
| Normal-vs-N1 |
1.787040E-01 |
| Normal-vs-N2 |
2.659900E-03 |
| N0-vs-N1 |
1.230030E-02 |
| N0-vs-N2 |
3.751800E-01 |
| N1-vs-N2 |
5.118600E-01 |
|
|
